
Company valuation, historical trends, and peer comparisons.
According to West Pharmaceutical Services, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 28.69B. This represents a change of 29.67% compared to the average of 22.12B of the last 4 quarters.
The mean historical Enterprise Value of West Pharmaceutical Services, Inc. over the last ten years is 17.25B. The current 28.69B Enterprise Value has changed 66.30% with respect to the historical average. Over the past ten years (40 quarters), WST's Enterprise Value was at its highest in in the December 2021 quarter at 34.50B. The Enterprise Value was at its lowest in in the March 2017 quarter at 6.04B.
Average
17.25B
Median
18.23B
Minimum
6.24B
Maximum
34.46B
Discovering the peaks and valleys of West Pharmaceutical Services, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 87.45%
Maximum Annual Enterprise Value = 34.46B
Minimum Annual Increase = -50.86%
Minimum Annual Enterprise Value = 6.24B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 19.52B | -17.76% |
| 2024 | 23.73B | -7.36% |
| 2023 | 25.62B | 51.28% |
| 2022 | 16.93B | -50.86% |
| 2021 | 34.46B | 66.89% |
| 2020 | 20.65B | 87.45% |
| 2019 | 11.01B | 55.07% |
| 2018 | 7.10B | -2.06% |
| 2017 | 7.25B | 16.16% |
| 2016 | 6.24B | 43.22% |
The current Enterprise Value of West Pharmaceutical Services, Inc. (WST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.96B
5-year avg
24.05B
10-year avg
17.25B
West Pharmaceutical Services, Inc.’s Enterprise Value is greater than Stevanato Group S.p.A. (5.27B), greater than AptarGroup, Inc. (10.21B), greater than Sartorius Stedim Biotech S.A. (23.93B), greater than Sartorius AG ADR (19.77B), greater than ICU Medical, Inc. (5.07B), greater than BioLife Solutions, Inc. (1.88B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.27B | $5.50B | |
| 10.21B | $9.00B | |
| 23.93B | $24.28B | |
| 19.77B | $94.80B | |
| 5.07B | $4.10B | |
| 1.88B | $1.89B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like West Pharmaceutical Services, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like West Pharmaceutical Services, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is West Pharmaceutical Services, Inc.'s Enterprise Value?
What is the highest Enterprise Value for West Pharmaceutical Services, Inc. (WST)?
What is the 3-year average Enterprise Value for West Pharmaceutical Services, Inc. (WST)?
What is the 5-year average Enterprise Value for West Pharmaceutical Services, Inc. (WST)?
How does the current Enterprise Value for West Pharmaceutical Services, Inc. (WST) compare to its historical average?